Pharmaceutical Law & Industry Report® Index-Summary

WARFARIN

– Anticoagulant drug, Medicare to cover clinical trial, 946

WARNINGS

See also LABELS AND PACKAGING; SAFETY
– Fanapt approved for adult schizophrenia with warning, 539
– Myfortic maker warns of anemia risk, 1051
– Over-the-counter drugs, In Brief, 510
– Raptiva adverse events, FDA issues advisory, 233
– TNF blockers risk, FDA requires stronger warning, 918

WASHINGTON

– Medicaid pharmacy reimbursement cuts blocked (W.D. Wash.), 403; agency to reexamine cuts, 592; agency to cut reimbursements, 621
– Plan B dispensing requirement, injunction vacated (9th Cir.), 823
– Tamper-resistant prescription pad bill signed, 593

WEIGHT LOSS PRODUCTS AND PROGRAMS

– Combination drug blamed for death (E.D. Pa.), 438
– Expert disqualified in diet drug suit (E.D. Pa.), 825
– Fen-phen settlement, attorneys convicted of bilking plaintiffs (E.D. Ky.), 467
– Redux, FDA approval preempts failure-to-warn claim (N.D. Ohio), 366
– Repose law bars product liability claim (6th Cir.), 1039
– Rimonabant securities fraud suit dismissed (S.D.N.Y.), 1135

WELLBUTRIN

– Antidepressant, direct purchaser antitrust suit may proceed (E.D. Pa.), 308
– Generic makers accused of making inferior product (Cal. Super. Ct.), 706
– U.S. rights purchased, In Brief, 540

WISCONSIN

– Average wholesale price, Atty. Gen. settles with drug firms (Wis. Cir. Ct.), 11
– Medicaid, Pharmacia defrauded program through inflated prices (Wis. Cir. Ct.), 200; forfeitures sought, 556

WOMEN'S HEALTH

– HRT

See HORMONE REPLACEMENT THERAPY (HRT)

WYOMING

– Internet, drug database access bill signed, 321